Doctor profile · Federal record

Dr. Chang Son, MD

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Englewood, NJ

  • NPI 1063493898
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 16 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
200 Grand Ave 201
Englewood, NJ 076314363
(201) 944-3800
fax (201) 944-3804
Additional location
243 Chestnut St Ste 3
Newark, NJ 071056501

Credentials & registration

NPPES · NUCC
NPI registered
November 2005 — 21 yrs on file
Profile last updated
February 12, 2023
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (2)
New Jersey #25MA08185100 · Pennsylvania #MD425589

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1063493898. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,043
Distinct HCPCS
10
Medicare allowed
$159,434
HCPCS Description Services Patients Avg allowed
99213 Established patient office or other outpatient visit, 20-29 minutes 601 334 $100
17003 Destruction of precancer skin growth, 2-14 growths 447 56 $8
11102 Biopsy of related skin growth, first growth 189 166 $113
99203 New patient office or other outpatient visit, 30-44 minutes 144 144 $124
11103 Biopsy of related skin growth, each additional growth 123 80 $58
17000 Destruction of precancer skin growth, 1 growth 114 68 $63
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 110 64 $1
17110 Destruction of skin growth, 1-14 growths 84 50 $129
11900 Injection into skin growth, 1-7 growths 77 55 $54
99214 Established patient office or other outpatient visit, 30-39 minutes 56 54 $141

In context: peer comparison

Among 2 peers in Englewood Dermatology Physician, average services per provider: 175. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$18,401
Transactions
94
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Incyte Corporation 15 $8,959.19
Amgen INC. 14 $8,527.22
Dermavant Sciences, INC. 23 $269.64
E.R. Squibb & Sons, L.L.C. 15 $167.97
Novartis Pharmaceuticals Corporation 6 $143.27
Lilly USA, LLC 5 $79.24
Arcutis Biotherapeutics, INC. 5 $75.58
Verrica Pharmaceuticals INC. 3 $42.36
Genzyme Corporation 2 $37.51
Abbvie INC. 2 $33.01
Biocon Biologics INC 1 $17.91
Celgene Corporation 1 $16.46
Galderma Laboratories, L.P. 1 $16.04
Pfizer INC. 1 $15.79

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$16,670
Food and Beverage
$1,731

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,163
Patients
1,660
Total drug cost
$366,137
Drug Type Claims Patients Total cost
Ketoconazole Generic 613 259 $13,087
Triamcinolone Acetonide Generic 595 364 $6,229
Mupirocin Generic 384 226 $5,880
Hydrocortisone Generic 285 191 $2,877
Clindamycin Phosphate Generic 174 71 $4,672
Clobetasol Propionate Generic 166 75 $11,435
Fluocinonide Generic 164 82 $8,635
Halobetasol Propionate Generic 164 78 $13,841
Ammonium Lactate Generic 151 75 $4,129
Levocetirizine Dihydrochloride Generic 145 94 $1,200

Frequently asked questions

Auto-generated from federal data
What is Dr. Chang Son's medical specialty?
Dr. Chang Son practices Dermatology Physician in Englewood, NJ.
Where does Dr. Chang Son practice?
Dr. Chang Son practices at 200 Grand Ave 201, Englewood, NJ 076314363. Office phone: 2019443800.
What is Dr. Chang Son's NPI?
Dr. Chang Son's National Provider Identifier (NPI) is 1063493898, issued by NPPES.
Does Dr. Chang Son accept Medicare assignment?
Yes. Dr. Chang Son accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Chang Son commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.